𝔖 Bobbio Scriptorium

✦ LIBER ✦

The challenges of new drugs benefits and risks analysis: Lessons from the ximelagatran FDA Cardiovascular Advisory Committee

✍ Scribed by Pol F. Boudes

Book ID: 116350565
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 135 KB
Volume: 27
Category: Article
ISSN: 1551-7144
DOI: 10.1016/j.cct.2006.04.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Modelling the market uptake of new drugs

Modelling the market uptake of new drugs following listing for subsidy in Australia. A report from the Drug Utilisation Subcommittee of the Australian Pharmaceutical Benefits Advisory Committee.

✍ DJ Birkett; P McManus 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 582 KB